Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Template:DangerousInteractions/MAOI: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
>ExistingEntity
Removing reference duplications across different templates
>ExistingEntity
Maybe not
Line 1: Line 1:
*'''[[DangerousInteraction::MAOIs]]''' - This combination may increase the amount of neurotransmitters such as {{{nt}}} to dangerous or even fatal levels. Examples include '''[[syrian rue]]''', '''[[banisteriopsis caapi]]''', '''[[2C-T-2]]''', '''[[2C-T-7]]''', '''[[αMT]]''', and some [[antidepressants]].<ref name="sertoxicity">Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity - P. K. Gillman | http://bja.oxfordjournals.org/content/95/4/434</ref>
*'''[[DangerousInteraction::MAOIs]]''' - This combination may increase the amount of neurotransmitters such as {{{nt}}} to dangerous or even fatal levels. Examples include '''[[syrian rue]]''', '''[[banisteriopsis caapi]]''', '''[[2C-T-2]]''', '''[[2C-T-7]]''', '''[[αMT]]''', and some [[antidepressants]].<ref>Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity - P. K. Gillman | http://bja.oxfordjournals.org/content/95/4/434</ref>

Revision as of 16:20, 15 April 2017

  1. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity - P. K. Gillman | http://bja.oxfordjournals.org/content/95/4/434